B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	Coherence
I-Diagnostic_tool	18	28	Tomography
I-Diagnostic_tool	29	40	Angiography
O	41	43	of
B-Disease	44	47	DME
O	48	51	and
O	52	55	Its
O	56	67	Association
O	68	72	with
O	73	77	Anti
O	77	78	-
O	78	82	VEGF
O	83	92	Treatment
O	93	101	Response
O	101	102	.

O	104	106	To
O	107	118	investigate
O	119	122	the
O	123	133	structural
O	134	143	integrity
O	144	146	of
O	147	150	the
B-Anatomy	151	162	superficial
I-Anatomy	163	172	capillary
I-Anatomy	173	181	plexuses
O	182	183	(
B-Anatomy	183	187	SCPs
O	187	188	)
O	189	192	and
B-Anatomy	193	197	deep
I-Anatomy	198	207	capillary
I-Anatomy	208	216	plexuses
O	217	218	(
B-Anatomy	218	222	DCPs
O	222	223	)
O	224	229	using
B-Diagnostic_tool	230	237	optical
I-Diagnostic_tool	238	247	coherence
I-Diagnostic_tool	248	258	tomography
I-Diagnostic_tool	259	260	(
I-Diagnostic_tool	260	263	OCT
I-Diagnostic_tool	263	264	)
I-Diagnostic_tool	265	276	angiography
O	277	278	(
B-Diagnostic_tool	278	282	OCTA
O	282	283	)
O	284	286	in
O	287	295	patients
O	296	300	with
B-Disease	301	309	diabetic
I-Disease	310	317	macular
I-Disease	318	323	edema
O	324	325	(
B-Disease	325	328	DME
O	328	329	)
O	330	333	and
O	334	337	its
O	338	349	association
O	350	354	with
O	355	358	the
O	359	367	response
O	368	370	to
O	371	375	anti
O	375	376	-
O	376	384	vascular
O	385	396	endothelial
O	397	403	growth
O	404	410	factor
O	411	412	(
O	412	416	VEGF
O	416	417	)
O	418	427	treatment
O	427	428	.

O	429	442	Retrospective
O	442	443	,
O	444	448	case
O	448	449	-
O	449	456	control
O	457	462	study
O	462	463	.

O	464	466	We
O	467	475	included
O	476	478	51
B-Disease	479	482	DME
B-Anatomy	483	487	eyes
O	488	492	with
O	493	494	a
O	495	499	poor
O	500	508	response
O	509	511	to
O	512	516	anti
O	516	517	-
O	517	521	VEGF
O	522	528	agents
O	529	532	and
O	533	535	32
B-Characteristic	536	539	age
O	539	540	-
O	540	547	matched
B-Disease	548	551	DME
B-Anatomy	552	556	eyes
O	557	561	with
O	562	563	a
O	564	568	good
O	569	577	response
O	578	580	to
O	581	585	anti
O	585	586	-
O	586	590	VEGF
O	591	600	treatment
O	600	601	,
O	602	607	along
O	608	612	with
O	613	615	20
O	616	622	fellow
B-Anatomy	623	627	eyes
O	628	635	without
B-Disease	636	639	DME
O	640	644	from
O	645	648	the
O	649	654	cases
O	655	658	and
O	659	667	controls
O	667	668	.

O	669	672	The
O	673	680	medical
O	681	688	records
O	688	689	,
O	690	699	including
B-Diagnostic_tool	700	704	OCTA
O	705	708	and
B-Diagnostic_tool	709	717	spectral
I-Diagnostic_tool	717	718	-
I-Diagnostic_tool	718	724	domain
I-Diagnostic_tool	725	728	OCT
O	729	730	(
B-Diagnostic_tool	730	732	SD
I-Diagnostic_tool	733	736	OCT
O	736	737	)
O	737	738	,
O	739	743	were
O	744	752	reviewed
O	753	756	and
O	757	765	compared
O	766	773	between
O	774	777	the
O	778	784	groups
O	784	785	.

O	786	788	En
O	789	793	face
B-Diagnostic_tool	794	798	OCTA
O	799	805	images
O	806	808	of
O	809	812	the
B-Anatomy	813	816	SCP
O	817	820	and
B-Anatomy	821	824	DCP
O	825	829	were
O	830	838	obtained
O	839	842	for
O	843	847	each
B-Anatomy	848	851	eye
O	851	852	.

O	853	855	An
O	856	860	anti
O	860	861	-
O	861	865	VEGF
O	866	875	responder
O	876	879	was
O	880	887	defined
O	888	890	by
O	891	892	a
O	893	902	reduction
O	903	905	of
O	906	910	more
O	911	915	than
O	916	918	50
O	919	920	μ
O	920	921	m
O	922	924	in
B-Characteristic	925	932	central
I-Characteristic	933	940	retinal
I-Characteristic	941	950	thickness
O	951	956	after
O	957	958	3
O	959	970	consecutive
O	971	975	anti
O	975	976	-
O	976	980	VEGF
O	981	991	treatments
O	991	992	.

O	993	994	A
O	995	999	poor
O	1000	1009	responder
O	1010	1013	was
O	1014	1021	defined
O	1022	1024	by
O	1025	1026	a
O	1027	1036	reduction
O	1037	1039	of
O	1040	1044	less
O	1045	1049	than
O	1050	1052	50
O	1053	1054	μ
O	1054	1055	m
O	1056	1058	or
O	1059	1061	an
O	1062	1070	increase
O	1071	1073	in
B-Characteristic	1074	1081	central
I-Characteristic	1082	1089	retinal
I-Characteristic	1090	1099	thickness
O	1100	1105	after
O	1106	1107	3
O	1108	1115	monthly
O	1116	1126	injections
O	1126	1127	.

O	1128	1130	We
O	1131	1139	measured
O	1140	1143	the
B-Characteristic	1144	1152	vascular
I-Characteristic	1153	1160	density
O	1161	1164	and
B-Characteristic	1165	1171	foveal
I-Characteristic	1172	1181	avascular
I-Characteristic	1182	1186	zone
I-Characteristic	1187	1188	(
I-Characteristic	1188	1191	FAZ
I-Characteristic	1191	1192	)
I-Characteristic	1193	1197	area
O	1198	1201	and
O	1202	1209	counted
O	1210	1213	the
B-Characteristic	1214	1220	number
I-Characteristic	1221	1223	of
I-Characteristic	1224	1238	microaneurysms
I-Characteristic	1239	1241	in
I-Characteristic	1242	1246	each
I-Characteristic	1247	1252	layer
O	1252	1253	.

O	1254	1257	The
B-Diagnostic_tool	1258	1260	SD
I-Diagnostic_tool	1261	1264	OCT
O	1265	1271	images
O	1272	1276	were
O	1277	1285	compared
O	1286	1290	with
B-Diagnostic_tool	1291	1295	OCTA
O	1296	1304	findings
O	1304	1305	.

O	1306	1314	Compared
O	1315	1319	with
B-Disease	1320	1323	non
I-Disease	1323	1324	-
I-Disease	1324	1327	DME
B-Anatomy	1328	1332	eyes
O	1332	1333	,
B-Disease	1334	1337	DME
B-Anatomy	1338	1342	eyes
O	1343	1346	had
O	1347	1348	a
B-Characteristic	1349	1354	lower
I-Characteristic	1355	1363	vascular
I-Characteristic	1364	1371	density
O	1372	1373	(
O	1373	1374	P
O	1376	1377	<
O	1379	1380	0
O	1380	1381	.
O	1381	1384	001
O	1384	1385	)
O	1386	1389	and
B-Characteristic	1390	1396	larger
I-Characteristic	1397	1400	FAZ
I-Characteristic	1401	1405	area
I-Characteristic	1406	1407	(
I-Characteristic	1407	1408	P
I-Characteristic	1410	1411	<
I-Characteristic	1413	1414	0
I-Characteristic	1414	1415	.
I-Characteristic	1415	1418	001
I-Characteristic	1418	1419	)
I-Characteristic	1420	1422	in
I-Characteristic	1423	1426	the
I-Characteristic	1427	1430	DCP
O	1431	1434	and
B-Symptom	1435	1439	more
I-Symptom	1440	1454	microaneurysms
O	1455	1456	(
O	1456	1457	P
O	1459	1460	<
O	1462	1463	0
O	1463	1464	.
O	1464	1467	001
O	1467	1468	)
O	1469	1471	in
O	1472	1476	both
O	1477	1483	layers
O	1483	1484	.

O	1485	1493	Although
O	1494	1499	there
O	1500	1503	was
O	1504	1506	no
O	1507	1518	significant
O	1519	1529	difference
O	1530	1532	in
O	1533	1536	the
B-Anatomy	1537	1540	SCP
O	1541	1548	between
O	1549	1553	anti
O	1553	1554	-
O	1554	1558	VEGF
O	1559	1569	responders
O	1570	1573	and
O	1574	1578	poor
O	1579	1589	responders
O	1589	1590	,
O	1591	1595	poor
O	1596	1606	responders
O	1607	1613	tended
O	1614	1616	to
O	1617	1621	show
O	1622	1629	greater
O	1630	1636	damage
O	1637	1640	and
B-Symptom	1641	1645	more
I-Symptom	1646	1660	microaneurysms
I-Symptom	1661	1663	in
I-Symptom	1664	1667	the
I-Symptom	1668	1671	DCP
O	1672	1673	(
O	1673	1674	P
O	1676	1677	<
O	1679	1680	0
O	1680	1681	.
O	1681	1684	001
O	1684	1685	)
O	1686	1689	and
O	1690	1691	a
B-Symptom	1692	1698	larger
I-Symptom	1699	1702	FAZ
I-Symptom	1703	1707	area
O	1708	1709	(
O	1709	1710	P
O	1712	1713	<
O	1715	1716	0
O	1716	1717	.
O	1717	1720	001
O	1720	1721	)
O	1721	1722	.

O	1723	1726	The
O	1727	1738	topographic
O	1739	1747	location
O	1748	1750	of
O	1751	1754	the
B-Symptom	1755	1764	disrupted
I-Symptom	1765	1773	synaptic
I-Symptom	1774	1781	portion
I-Symptom	1782	1784	of
I-Symptom	1785	1788	the
I-Symptom	1789	1794	outer
I-Symptom	1795	1804	plexiform
I-Symptom	1805	1810	layer
O	1811	1812	(
B-Anatomy	1812	1815	OPL
O	1815	1816	)
O	1817	1819	in
B-Diagnostic_tool	1820	1822	SD
I-Diagnostic_tool	1823	1826	OCT
O	1827	1834	exactly
O	1835	1847	corresponded
O	1848	1850	to
O	1851	1854	the
O	1855	1862	nonflow
O	1863	1867	area
O	1868	1870	of
O	1871	1874	the
B-Anatomy	1875	1878	DCP
O	1879	1881	in
B-Diagnostic_tool	1882	1886	OCTA
O	1886	1887	.

O	1888	1896	Compared
O	1897	1901	with
B-Disease	1902	1905	DME
B-Anatomy	1906	1910	eyes
O	1911	1915	that
O	1916	1925	responded
O	1926	1928	to
O	1929	1933	anti
O	1933	1934	-
O	1934	1938	VEGF
O	1939	1948	treatment
O	1948	1949	,
O	1950	1954	poor
O	1955	1965	responders
O	1966	1970	show
O	1971	1982	significant
O	1983	1989	damage
O	1990	1992	to
O	1993	1996	the
O	1997	2006	integrity
O	2007	2009	of
O	2010	2013	the
B-Anatomy	2014	2017	DCP
O	2017	2018	,
O	2019	2022	but
O	2023	2026	not
O	2027	2030	the
B-Anatomy	2031	2034	SCP
O	2034	2035	.

O	2036	2039	The
O	2040	2046	degree
O	2047	2049	of
B-Symptom	2050	2053	OPL
I-Symptom	2054	2064	disruption
O	2065	2067	in
B-Diagnostic_tool	2068	2070	SD
I-Diagnostic_tool	2071	2074	OCT
O	2075	2086	corresponds
O	2087	2091	well
O	2092	2096	with
O	2097	2100	the
O	2101	2107	extent
O	2108	2110	of
B-Symptom	2111	2114	DCP
I-Symptom	2115	2119	loss
O	2120	2122	in
B-Disease	2123	2126	DME
B-Anatomy	2127	2131	eyes
O	2131	2132	.

O	2133	2136	The
O	2137	2143	extent
O	2144	2146	of
B-Symptom	2147	2150	DCP
I-Symptom	2151	2155	loss
O	2156	2159	and
O	2160	2163	the
O	2164	2177	corresponding
B-Symptom	2178	2181	OPL
I-Symptom	2182	2192	disruption
O	2193	2198	could
O	2199	2201	be
O	2202	2208	useful
O	2209	2219	predictors
O	2220	2222	of
O	2223	2237	responsiveness
O	2238	2240	to
O	2241	2245	anti
O	2245	2246	-
O	2246	2250	VEGF
O	2251	2260	treatment
O	2260	2261	.
